original ) (raw )Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Paolo Monardo
Journal of Clinical Medicine
View PDFchevron_right
The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
Natasha McIntyre
PloS one, 2015
View PDFchevron_right
Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
Sophie Liabeuf
Toxins
View PDFchevron_right
Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study
Jayne Parkes
Journal of Clinical Pathology, 2012
View PDFchevron_right
Free Light Chains of Immunoglobulin as a Prognostic Factor for Some Plasmaproliferative Diseases
Slobodan Marjanovic
Journal of Medical Biochemistry, 2000
View PDFchevron_right
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
Björn Meijers
Kidney International Reports
View PDFchevron_right
The Importance of Free Light Chains of Immunoglobulins Determination in Serum
Mirjana Đerić
Journal of Medical Biochemistry, 2007
View PDFchevron_right
The association of serum-free light-chain levels with markers of renal function
Bilge Karatoy Erdem
Renal Failure, 2015
View PDFchevron_right
The role of free immunoglobulin light chains in serum from SLE patients with or without renal involvement
Marcos Meneses-Mayo
Blood and Genomics
View PDFchevron_right
Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients
Bernard Canaud
Journal of Nephrology, 2015
View PDFchevron_right
Serum free light chain quantitative assays: Dilemma of a biomarker
Giovanni Cigliana
Journal of clinical laboratory analysis, 2017
View PDFchevron_right
Extended Use of Serum Free Light Chain as a Biomarker in Lymphoproliferative Disorders: A Comprehensive Review
Mark Jabbour
American Journal of Clinical Pathology, 2012
View PDFchevron_right
Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant
Rodrigo Fernando
Leukemia & Lymphoma, 2013
View PDFchevron_right
Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays
Thibault Cavey
Clinical Lymphoma Myeloma and Leukemia, 2016
View PDFchevron_right
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
Sotirios Sachanas
Advances in Hematology, 2013
View PDFchevron_right
Serum free light chains in clinical laboratory diagnostics
Yun Wang
View PDFchevron_right
Article Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
Horst-Dieter Lemke
2013
View PDFchevron_right
The relationship between high-sensitivity CRP and polyclonal Free Light Chains as markers of inflammation in chronic disease
Anthony Barnett
International Journal of Laboratory Hematology, 2013
View PDFchevron_right
A multicentre study comparing two methods for serum free light chain analysis
Anthony Rowbottom
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
View PDFchevron_right
Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Miguel Fernández-Arquero
Frontiers in Immunology, 2020
View PDFchevron_right
Free immunoglobulin light chains: A role in minimal change disease
Georges Deschenes
Bioscience Hypotheses, 2009
View PDFchevron_right
Renal Expression of Light Chain Binding Proteins
Ludwig Wagner
Frontiers in Medicine, 2021
View PDFchevron_right
Immunoglobulin free light chains: do they have a role in plasma cell leukemia?
Rakhee Kar
Hematology, 2008
View PDFchevron_right
Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
Tim Plant
Clinical chemistry and laboratory medicine, 2016
View PDFchevron_right
Novel approaches for reducing free light chains in patients with myeloma kidney
Efstathios Kastritis
2012
View PDFchevron_right
Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint
Mehdi Maghbooli
Journal of Renal Injury Prevention, 2016
View PDFchevron_right
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Kari Rabe
Blood, 2011
View PDFchevron_right
Polyclonal versus monoclonal immunoglobulin-free light chains quantification
Lucia Paolini , Annalisa Radeghieri
Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, 2014
View PDFchevron_right
Comparison of free light chain removal by four blood purification methods
Nobuhiko Emi
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2011
View PDFchevron_right
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
Guy Pratt
British Journal of Haematology, 2009
View PDFchevron_right
Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma
Luis Porrata
American Journal of Hematology, 2011
View PDFchevron_right